XML 52 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Net revenues (Tables)
 12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table disaggregates revenue by global product category for the year ended December 31, 2021, 2020 and 2019.
Year Ended December 31
202120202019
Vascular access$700,240 $657,703 $600,874 
Anesthesia380,140 302,293 338,413 
Interventional427,500 382,435 427,563 
Surgical377,756 317,200 370,074 
Interventional urology341,661 290,022 290,449 
OEM245,681 220,246 220,717 
Other (1)
336,585 367,257 347,272 
Net revenues (2)
$2,809,563 $2,537,156 $2,595,362 
(1) Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). Certain product lines within the respiratory product category were sold during 2021. See Note 4 for additional information related to the Respiratory business divestiture.
(2) The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.